Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Crispr Therapeutics Ag (CRSP)

63.67   -1.28 (-1.97%) 06-04 16:00
Open: 65.12 Pre. Close: 64.95
High: 66.36 Low: 62.56
Volume: 687,543 Market Cap: 3,885M
CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 66.428 - 66.791 66.791 - 67.092
Low: 61.707 - 62.146 62.146 - 62.51
Close: 63.001 - 63.679 63.679 - 64.241

Technical analysis

as of: 2020-06-04 4:30:03 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 82.93     One year: 96.86
Support: Support1: 56.07    Support2: 46.84
Resistance: Resistance1: 71.00    Resistance2: 82.93
Pivot: 64.65
Moving Average: MA(5): 65.63     MA(20): 62.76
MA(100): 52.42     MA(250): 51.57
MACD: MACD(12,26): 3.48     Signal(9): 3.90
Stochastic oscillator: %K(14,3): 67.64     %D(3): 71.89
RSI: RSI(14): 55.49
52-week: High: 74.00  Low: 32.30  Change(%): 48.5
Average Vol(K): 3-Month: 93065  10-Days: 94294

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CRSP has closed above bottom band by 42.5%. Bollinger Bands are 1.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 03 Jun 2020
Jun 03, 2020 - Crispr Therapeutics Ag (CRSP) CEO Samarth Kulkarni Sold $1.1 million of Shares -

Tue, 26 May 2020
CRISPR Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

Thu, 14 May 2020
News Flash: Analysts Just Made A Substantial Upgrade To Their CRISPR Therapeutics AG (NASDAQ:CRSP) Forecasts - Yahoo Finance

Thu, 04 Jun 2020
July 24th Options Now Available For CRISPR Therapeutics (CRSP) - Nasdaq

Thu, 14 May 2020
Crispr Therapeutics AG (CRSP) Received its Third Buy in a Row - Smarter Analyst

Fri, 15 May 2020
CRISPR Therapeutics Announces Presentations at the American Association for Cancer Research 2020 Annual Meeting - GlobeNewswire

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 61
Shares Float (M) 46
% Held by Insiders 20.94
% Held by Institutions 55.73
Shares Short (K) 4,020
Shares Short P. Month (K) 3,270

Stock Financials

EPS 0.770
EPS Est This Year -2.430
EPS Est Next Year -3.020
Book Value (p.s.) 14.550
Profit Margin 15.73
Operating Margin 7.46
Return on Assets (ttm) 1.8
Return on Equity (ttm) 7.2
Qtrly Rev. Growth -52.1
Gross Profit (p.s.) 1.806
Sales Per Share 4.743
EBITDA (p.s.) 0.452
Qtrly Earnings Growth
Operating Cash Flow (M) 48
Levered Free Cash Flow (M) 55

Stock Valuations

PE Ratio 82.69
PEG Ratio
Price to Book value 4.38
Price to Sales 13.42
Price to Cash Flow 80.54

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.